Source: PRWeb

Press Release: ZeptoMetrix : ZeptoMetrix Launches New Ready-to-Use SARS-CoV-2 Omicron Variant Molecular Quality Controls

ZeptoMetrix®, an Antylia Scientific company, adds one more addition to its expansive line of infectious disease quality controls and is now available for pre-order.(PRWeb February 04, 2022)Read the full story at https://www.prweb.com/releases/zeptometrix_launches_new_ready_to_use_sars_cov_2_omicron_variant_molecular_quality_controls/prweb18480133.htm

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Shawn R. Smith's photo - President & CEO of ZeptoMetrix

President & CEO

Shawn R. Smith

CEO Approval Rating

88/100

Read more